Discovery of a selective c-MET inhibitor with a novel binding mode

Bioorg Med Chem Lett. 2022 Nov 1:75:128948. doi: 10.1016/j.bmcl.2022.128948. Epub 2022 Aug 17.

Abstract

The c-MET receptor tyrosine kinase has received considerable attention as a cancer drug target yet there remains a need for inhibitors which are selective for c-MET and able to target emerging drug-resistant mutants. We report here the discovery, by screening a DNA-encoded chemical library, of a highly selective c-MET inhibitor which was shown by X-ray crystallography to bind to the kinase in an unprecedented manner. These results represent a novel mode of inhibiting c-MET with a small molecule and may provide a route to targeting drug-resistant forms of the kinase whilst avoiding potential toxicity issues associated with broad kinome inhibition.

Keywords: DNA-encoded chemical library; Drug-resistance; Kinase; Small molecule inhibitor; c-MET.

MeSH terms

  • Antineoplastic Agents* / pharmacology
  • Cell Line, Tumor
  • DNA
  • Protein Kinase Inhibitors / chemistry
  • Proto-Oncogene Proteins c-met*
  • Small Molecule Libraries / chemistry

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Small Molecule Libraries
  • DNA
  • Proto-Oncogene Proteins c-met